FULC
Price
$8.85
Change
+$0.35 (+4.12%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
459.78M
47 days until earnings call
ORMP
Price
$2.41
Change
+$0.01 (+0.42%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
98.41M
49 days until earnings call
Interact to see
Advertisement

FULC vs ORMP

Header iconFULC vs ORMP Comparison
Open Charts FULC vs ORMPBanner chart's image
Fulcrum Therapeutics
Price$8.85
Change+$0.35 (+4.12%)
Volume$5.85K
Capitalization459.78M
Oramed Pharmaceuticals
Price$2.41
Change+$0.01 (+0.42%)
VolumeN/A
Capitalization98.41M
FULC vs ORMP Comparison Chart in %
Loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FULC vs. ORMP commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a Buy and ORMP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (FULC: $8.85 vs. ORMP: $2.41)
Brand notoriety: FULC and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 47% vs. ORMP: 26%
Market capitalization -- FULC: $459.78M vs. ORMP: $98.41M
FULC [@Biotechnology] is valued at $459.78M. ORMP’s [@Biotechnology] market capitalization is $98.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than FULC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 6 TA indicator(s) are bullish while ORMP’s TA Score has 5 bullish TA indicator(s).

  • FULC’s TA Score: 6 bullish, 4 bearish.
  • ORMP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, FULC is a better buy in the short-term than ORMP.

Price Growth

FULC (@Biotechnology) experienced а +19.76% price change this week, while ORMP (@Biotechnology) price change was +2.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

FULC is expected to report earnings on Nov 12, 2025.

ORMP is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FULC($460M) has a higher market cap than ORMP($98.4M). FULC YTD gains are higher at: 80.851 vs. ORMP (-0.413). ORMP has higher annual earnings (EBITDA): -22.07M vs. FULC (-81.28M). FULC has more cash in the bank: 214M vs. ORMP (97.9M). ORMP has less debt than FULC: ORMP (912K) vs FULC (7.57M). ORMP has higher revenues than FULC: ORMP (2M) vs FULC (0).
FULCORMPFULC / ORMP
Capitalization460M98.4M467%
EBITDA-81.28M-22.07M368%
Gain YTD80.851-0.413-19,566%
P/E RatioN/A20.91-
Revenue02M-
Total Cash214M97.9M219%
Total Debt7.57M912K830%
FUNDAMENTALS RATINGS
FULC vs ORMP: Fundamental Ratings
FULC
ORMP
OUTLOOK RATING
1..100
1678
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
53
Fair valued
PROFIT vs RISK RATING
1..100
96100
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
3649
P/E GROWTH RATING
1..100
10043
SEASONALITY SCORE
1..100
2485

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FULC's Valuation (25) in the null industry is in the same range as ORMP (53) in the Pharmaceuticals Other industry. This means that FULC’s stock grew similarly to ORMP’s over the last 12 months.

FULC's Profit vs Risk Rating (96) in the null industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that FULC’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (95) in the Pharmaceuticals Other industry is in the same range as FULC (97) in the null industry. This means that ORMP’s stock grew similarly to FULC’s over the last 12 months.

FULC's Price Growth Rating (36) in the null industry is in the same range as ORMP (49) in the Pharmaceuticals Other industry. This means that FULC’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's P/E Growth Rating (43) in the Pharmaceuticals Other industry is somewhat better than the same rating for FULC (100) in the null industry. This means that ORMP’s stock grew somewhat faster than FULC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FULCORMP
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 18 days ago
85%
Bearish Trend 10 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLPEY9.65N/A
N/A
Galp Energia, SA
BRSF0.75N/A
N/A
Brain Scientific, Inc.
CHSTF0.14N/A
N/A
China High Speed Transmission Equipment Group Co., Ltd.
CYYNF0.12N/A
N/A
Cynata Therapeutics Ltd.
LYSFF5.15N/A
N/A
Leroy Seafood Group ASA

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with ADPT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
+3.03%
ADPT - FULC
48%
Loosely correlated
+2.42%
TRDA - FULC
47%
Loosely correlated
+8.35%
OCUL - FULC
45%
Loosely correlated
-2.55%
BEAM - FULC
45%
Loosely correlated
-2.12%
VRDN - FULC
42%
Loosely correlated
-2.15%
More

ORMP and

Correlation & Price change

A.I.dvisor tells us that ORMP and BCAB have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORMP and BCAB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
+0.42%
BCAB - ORMP
29%
Poorly correlated
+5.92%
VALN - ORMP
29%
Poorly correlated
-2.51%
FULC - ORMP
28%
Poorly correlated
+4.12%
PRLD - ORMP
27%
Poorly correlated
+23.44%
SONN - ORMP
27%
Poorly correlated
-3.00%
More